Ranking · Winter 2018 · Healthcare · Drug Discovery and Delivery

Sixfold Bioscience

Delivering RNA therapies.

3.6%

odds of being acquired in the next two years

0.5× the average (6.8%)

#4218 of 4,339 active YC companies · top 98%

Team of 27 · London, England, United Kingdom

Raises the odds

↑ changed its name (pivot)

Lowers the odds

↓ industry: Healthcare

↓ sector: Drug Discovery and Delivery

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Sixfold Bioscience's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

sixfold.bio YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub